Gross Profit Summary of Viveve Medical, Inc.

Viveve Medical, Inc.'s latest annual gross profit in 2021 was 620 Thousand USD , up 109.46% from previous year.
Viveve Medical, Inc.'s latest quarterly gross profit in 2022 Q3 was 546 Thousand USD , up 85.71% from previous quarter.
Viveve Medical, Inc. reported a annual gross profit of 296 Thousand USD in annual gross profit 2020, down -70.87% from previous year.
Viveve Medical, Inc. reported a annual gross profit of 1.01 Million USD in annual gross profit 2019, down -86.12% from previous year.
Viveve Medical, Inc. reported a quarterly gross profit of 294 Thousand USD for 2022 Q2, down -8.13% from previous quarter.
Viveve Medical, Inc. reported a quarterly gross profit of 320 Thousand USD for 2022 Q1, up 880.49% from previous quarter.

Annual Gross Profit Chart of Viveve Medical, Inc. (2021 - 1990)

Historical Annual Gross Profit of Viveve Medical, Inc. (2021 - 1990)

Year	Gross Profit	Gross Profit Growth
2021	620 Thousand USD	109.46%
2020	296 Thousand USD	-70.87%
2019	1.01 Million USD	-86.12%
2018	7.32 Million USD	-1.67%
2017	7.44 Million USD	194.35%
2016	2.52 Million USD	447.4%
2015	462 Thousand USD	1055.0%
2014	40 Thousand USD	-94.62%
2013	743 Thousand USD	37.85%
2012	539 Thousand USD	120.0%
2011	245 Thousand USD	-90.34%
2010	2.53 Million USD	-2.99%
2009	2.61 Million USD	-16.52%
2008	3.13 Million USD	-7.09%
2007	3.36 Million USD	-23.67%
2006	4.41 Million USD	-3.41%
2005	4.57 Million USD	1.47%
2004	4.5 Million USD	-9.76%
2003	4.99 Million USD	5.16%
2002	4.74 Million USD	13.3%
2001	4.18 Million USD	-39.71%
2000	6.94 Million USD	-16.67%
1999	8.33 Million USD	93.91%
1998	4.3 Million USD	-23.21%
1997	5.6 Million USD	-37.78%
1996	9 Million USD	-3.23%
1995	9.3 Million USD	244.44%
1994	2.7 Million USD	350.0%
1993	600 Thousand USD	20.0%
1992	500 Thousand USD	400.0%
1991	100 Thousand USD	0.0%
1990	100 Thousand USD	0.0%

Year	Gross Profit	Gross Profit Growth
2022 Q3	546 Thousand USD	85.71%
2022 Q2	294 Thousand USD	-8.13%
2022 Q1	320 Thousand USD	880.49%
2021 Q2	165 Thousand USD	-56.81%
2021 Q3	114 Thousand USD	-30.91%
2021 Q4	-41 Thousand USD	-135.96%
2021 FY	620 Thousand USD	109.46%
2021 Q1	382 Thousand USD	54.66%
2020 Q3	241 Thousand USD	165.67%
2020 Q1	175 Thousand USD	247.06%
2020 Q2	-367 Thousand USD	-309.71%
2020 Q4	247 Thousand USD	2.49%
2020 FY	296 Thousand USD	-70.87%
2019 Q3	-47 Thousand USD	-142.34%
2019 Q1	1.07 Million USD	-35.68%
2019 Q4	-119 Thousand USD	-153.19%
2019 Q2	111 Thousand USD	-89.64%
2019 FY	1.01 Million USD	-86.12%
2018 Q3	1.49 Million USD	-46.91%
2018 Q1	1.34 Million USD	-51.41%
2018 Q2	2.81 Million USD	108.91%
2018 FY	7.32 Million USD	-1.67%
2018 Q4	1.66 Million USD	11.45%
2017 Q1	1.42 Million USD	48.74%
2017 FY	7.44 Million USD	194.35%
2017 Q4	2.77 Million USD	37.84%
2017 Q3	2.01 Million USD	62.31%
2017 Q2	1.23 Million USD	-12.87%
2016 Q3	691 Thousand USD	29.4%
2016 Q4	956 Thousand USD	38.35%
2016 Q1	348 Thousand USD	21.25%
2016 Q2	534 Thousand USD	53.45%
2016 FY	2.52 Million USD	447.4%
2015 Q2	20 Thousand USD	266.67%
2015 Q3	167 Thousand USD	735.0%
2015 Q1	-12 Thousand USD	-176.92%
2015 FY	462 Thousand USD	1055.0%
2015 Q4	287 Thousand USD	71.86%
2014 Q3	2456.00 USD	-94.99%
2014 FY	40 Thousand USD	-94.62%
2014 Q1	23 Thousand USD	-79.46%
2014 Q2	49 Thousand USD	113.04%
2014 Q4	15.6 Thousand USD	535.18%
2013 Q3	224 Thousand USD	-5.49%
2013 Q1	169 Thousand USD	-32.94%
2013 FY	743 Thousand USD	37.85%
2013 Q4	112 Thousand USD	-50.0%
2013 Q2	237 Thousand USD	40.24%
2012 Q3	128 Thousand USD	-15.79%
2012 Q2	152 Thousand USD	2071.43%
2012 Q1	7000.00 USD	-94.07%
2012 FY	539 Thousand USD	120.0%
2012 Q4	252 Thousand USD	96.88%
2011 Q4	118 Thousand USD	1080.0%
2011 FY	245 Thousand USD	-90.34%
2011 Q2	200 Thousand USD	340.96%
2011 Q1	-83 Thousand USD	-111.34%
2011 Q3	10 Thousand USD	-95.0%
2010 FY	2.53 Million USD	-2.99%
2010 Q3	655 Thousand USD	0.0%
2010 Q1	493 Thousand USD	30.42%
2010 Q2	655 Thousand USD	32.86%
2010 Q4	732 Thousand USD	11.76%
2009 Q3	523 Thousand USD	-30.91%
2009 Q1	955 Thousand USD	10.92%
2009 Q4	378 Thousand USD	-27.72%
2009 FY	2.61 Million USD	-16.52%
2009 Q2	757 Thousand USD	-20.73%
2008 Q1	763 Thousand USD	17.38%
2008 FY	3.13 Million USD	-7.09%
2008 Q4	861 Thousand USD	11.96%
2008 Q3	769 Thousand USD	4.34%
2008 Q2	737 Thousand USD	-3.41%
2007 FY	3.36 Million USD	-23.67%
2007 Q4	650 Thousand USD	-24.68%
2007 Q2	1.15 Million USD	65.52%
2007 Q1	699 Thousand USD	-31.34%
2007 Q3	863 Thousand USD	-25.41%
2006 Q2	1.22 Million USD	1.92%
2006 FY	4.41 Million USD	-3.41%
2006 Q1	1.19 Million USD	11.13%
2006 Q4	1.01 Million USD	4.2%
2006 Q3	977 Thousand USD	-19.98%
2005 FY	4.57 Million USD	1.47%
2005 Q4	1.07 Million USD	-0.65%
2005 Q3	1.08 Million USD	-8.98%
2005 Q1	1.21 Million USD	-3.26%
2005 Q2	1.19 Million USD	-1.89%
2004 Q3	1.05 Million USD	0.67%
2004 Q2	1.04 Million USD	-8.22%
2004 Q1	1.14 Million USD	-9.57%
2004 FY	4.5 Million USD	-9.76%
2004 Q4	1.25 Million USD	18.94%
2003 Q2	1.38 Million USD	26.9%
2003 FY	4.99 Million USD	5.16%
2003 Q3	1.24 Million USD	-10.09%
2003 Q4	1.26 Million USD	1.36%
2003 Q1	1.09 Million USD	-11.93%
2002 Q4	1.24 Million USD	0.89%
2002 FY	4.74 Million USD	13.3%
2002 Q3	1.23 Million USD	-3.98%
2002 Q2	1.28 Million USD	28.87%
2002 Q1	994 Thousand USD	40.0%
2001 Q4	710 Thousand USD	-35.63%
2001 Q3	1.1 Million USD	-6.76%
2001 Q2	1.18 Million USD	-0.84%
2001 Q1	1.19 Million USD	-11.04%
2001 FY	4.18 Million USD	-39.71%
2000 Q1	1.38 Million USD	-45.51%
2000 Q2	2.49 Million USD	80.4%
2000 Q3	1.72 Million USD	-30.7%
2000 Q4	1.34 Million USD	-22.44%
2000 FY	6.94 Million USD	-16.67%
1999 Q4	2.53 Million USD	81.29%
1999 Q3	1.4 Million USD	-33.33%
1999 Q2	2.1 Million USD	0.0%
1999 Q1	2.1 Million USD	-8.7%
1999 FY	8.33 Million USD	93.91%
1998 Q1	800 Thousand USD	-11.11%
1998 Q3	900 Thousand USD	200.0%
1998 Q4	2.3 Million USD	155.56%
1998 FY	4.3 Million USD	-23.21%
1998 Q2	300 Thousand USD	-62.5%
1997 Q2	2.3 Million USD	91.67%
1997 Q3	1.2 Million USD	-47.83%
1997 FY	5.6 Million USD	-37.78%
1997 Q1	1.2 Million USD	-40.0%
1997 Q4	900 Thousand USD	-25.0%
1996 Q1	3.6 Million USD	-51.35%
1996 Q4	2 Million USD	0.0%
1996 Q3	2 Million USD	53.85%
1996 Q2	1.3 Million USD	-63.89%
1996 FY	9 Million USD	-3.23%
1995 Q2	1.5 Million USD	-48.28%
1995 Q3	1.6 Million USD	6.67%
1995 Q4	7.4 Million USD	362.5%
1995 Q1	2.9 Million USD	163.64%
1995 FY	9.3 Million USD	244.44%
1994 Q1	800 Thousand USD	300.0%
1994 FY	2.7 Million USD	350.0%
1994 Q3	300 Thousand USD	-40.0%
1994 Q4	1.1 Million USD	266.67%
1994 Q2	500 Thousand USD	-37.5%
1993 Q4	200 Thousand USD	100.0%
1993 FY	600 Thousand USD	20.0%
1993 Q1	200 Thousand USD	0.0%
1993 Q2	100 Thousand USD	-50.0%
1993 Q3	100 Thousand USD	0.0%
1992 Q4	- USD	-100.0%
1992 Q1	- USD	0.0%
1992 Q3	300 Thousand USD	50.0%
1992 Q2	200 Thousand USD	0.0%
1992 FY	500 Thousand USD	400.0%
1991 Q4	- USD	-100.0%
1991 Q2	100 Thousand USD	0.0%
1991 Q3	100 Thousand USD	0.0%
1991 Q1	100 Thousand USD	0.0%
1991 FY	100 Thousand USD	0.0%
1990 FY	100 Thousand USD	0.0%
1990 Q3	100 Thousand USD	0.0%
1990 Q2	100 Thousand USD	0.0%
1990 Q1	100 Thousand USD	0.0%
1990 Q4	- USD	-100.0%

Peer Gross Profit Comparison of Viveve Medical, Inc.

Name	Gross Profit	Gross Profit Difference
Acutus Medical, Inc.	-3.13 Million USD	119.764%
Biotricity, Inc.	8.35 Million USD	92.58%
Cell MedX Corp.	- USD	-Infinity%
Dynatronics Corporation	7.63 Million USD	91.879%
Nemaura Medical Inc.	-1.47 Million USD	141.994%
PetVivo Holdings, Inc.	739.52 Thousand USD	16.163%
RetinalGenix Technologies Inc.	-100.00 USD	620100.0%
Sonendo, Inc.	10.72 Million USD	94.217%
Telesis Bio, Inc.	16.95 Million USD	96.342%
Talis Biomedical Corporation	371 Thousand USD	-67.116%

Global Stocks Search

Viveve Medical, Inc. (VIVE)

Gross Profit Summary of Viveve Medical, Inc.

Annual Gross Profit Chart of Viveve Medical, Inc. (2021 - 1990)

Historical Annual Gross Profit of Viveve Medical, Inc. (2021 - 1990)

Peer Gross Profit Comparison of Viveve Medical, Inc.